The Federal Institute for Drugs and Medical Devices (BfArM) is responsible for the further development of LOINC for the concerns in Germany and for the provision of translations for the electronic patient record in accordance with § 355 Para. 7 Social Code Book V.

The Regenstrief Institute provides a wealth of information to help work with LOINC.

The Federal Institute for Drugs and Medical Devices (BfArM) oversees the translation of LOINC identifiers for Germany and submits them to the Regenstrief Institute. The translation activities are supported by experts.

Requests for additions or changes to LOINC concepts are submitted directly to the Regenstrief Institute. The Federal Institute for Drugs and Medical Devices (BfArM) offers to coordinate requests and to assist with submission.

The LOINC AG of the Advisory Board for Classifications in Health Care (KKG) advises the Federal Ministry of Health (BMG) and the Federal Institute for Drugs and Medical Devices (BfArM), which is subordinate to the BMG, on questions regarding the strategic further development and application of LOINC in Germany, on the coordination of changes resulting from national and international issues, on contributions to translations, and on the preparation of the German position for the European and international committees.